Ukulinganisa i-CRP ingaba luleke kwiMpilo yakho yeCardiac
Ukulinganisa ama-protein (CRP) asebenzayo (C-reactive levels) (CRP) angaba luncedo ekuhloleni umngcipheko we- coronary disease (CAD) kwabanye abantu. I-CRP yiprothini ekhishwa kwigazi ngexesha lee-inflammation. Ekubeni ukuvuvukala ngoku kwaziwa ngokudlala indima enkulu ekuphuhliseni i- atherosclerosis (inkqubo eyenza iiplates kwiimitha ze-arteries), kunengqiqo ukuba amazinga e-CRP angaphakanyiswa ngexesha lobunzima bokusekwa kweplate kwaye amazinga aphakamileyo e-CRP aya kuhambelana iziganeko zenhliziyo.
Izifundo ngoku zibonise ukuba i-CRP ephakamileyo idibene nomngcipheko okwandisiweyo weziganeko zentliziyo, ezifana nokuhlaselwa yintliziyo kunye nesifo . Kungakhathaliseki ukuba i-CRP ngokwenene ibangela umngcipheko okhulayo okanye umane nje ummakishi wengozi iqhutywe ingxoxo, nangona ukuxhomekeka kokubungqina kubonisa ukuba akusiyo imbangela ngqo. Sekunjalo, ngoku kuyaziwa ukuba ukuphatha abantu abanezinga eliphezulu ze-CRP kunye nama-statins kunokunciphisa ingozi. Le ngongoma yodwa yenza ukuba i-CRP ilandeleke kwabanye abantu.
I-CRP ilinganiswa njani?
I-CRP ilinganiswa ngokusebenzisa uvavanyo oluphezulu lokuvakala (olubizwa ngokuba yi-hs-CRP yegazi). Ngokubanzi, iphakamileyo ye-hs-CRP, iphakamileyo ingozi. Amanqanaba e-hs-CRP angaphantsi kwe-1 athatyathwa njengezantsi; amanqanaba oku-1 ukuya ku-3 athatyathwa njengamanani aphezulu; Amanqanaba angaphezu kwe-3 athathwa njengophakamileyo. Amanqanaba angaphezulu kwe-10 ayabonakala kuphela ngeenkqubo ezichanekileyo, ezivuthayo ezinokubandezeleka, ezifana nokusuleleka kakhulu, izifo ezinzima, okanye izifo ezingapheliyo-ezi nqanaba eziphezulu azikwazi ukusetyenziswa ukutshintsha ingozi yomzimba .
Ngenxa yokuba amanqanaba e-CRP angashintsha ngokuhamba kwexesha, ezininzi iingcali zincoma ukulinganisa amazinga e-CRP ezimbini kwiiveki ezimbalwa kunye nokulinganisela ixabiso lembini.
Ukugqiba ukuba ngaba ukulinganisa i-CRP kufuneka ibe yinxalenye yenkqubo yokuhlola inkqubo kuye kwaba nzima kwizizathu ezibini. Okokuqala, ukutolika ukubaluleka kwinqanaba le-CRP eliphakamileyo kaninzi lingaqondani, kwaye kunokukhokelela ekudidekeni okungakumbi kunokuba ngaphantsi.
Okwesibini, kwada kwada kwacaca ukuba unyango kufuneka litshintshwe kunoma ubani ngokusekelwe kwiziphumo zexabiso leRPP.
Xa Kukunceda Ukulinganisa I-CRP?
Amanqanaba aphakamileyo e-CRP ahlala edibaniswa nobuninzi bezinye izinto ezinobungozi zesifo senhliziyo ezifana nokutshaya, ukukhuluphala, ukuphila ngokwexesha lokuhlala , ukwanda kwe-cholesterol, uxinzelelo lwegazi kunye nesifo se-metabolic syndrome . Amanqanaba aphezulu e-CRP aqheleke kubonakala kwizigulane ezinenani elikhulu kunobungozi obongeziweyo. Kule meko, ukufumana umgangatho ophezulu we-CRP uqinisekisa nje oko kubonakala ngokubonakalayo-isigulane sinomngcipheko ophezulu wesifo senhliziyo , kwaye idinga ukuguqulwa komngcipheko wecala (ubuninzi kubandakanya i-statins) nayiphi na amanqanaba e-CRP.
Ngakolunye uhlangothi, i-CRP ephakamileyo kwinqanaba lomntu onomnye omnye okanye ezimbini izinto ezinobungozi zongeza ulwazi olubalulekileyo. Kuba bantu, inqanaba eliphezulu le-CRP lubonakala libonisa ukuba umngcipheko wabo uphezulu kunokuba ubonakale. Kuthetha ukuba incinci yexinzelelo, okanye ubuncinci obuncinane, ngokuqinisekileyo inxulumene nokutshabalala kwimithambo yegazi kunye nokuba ingozi yemicimbi ye-cardiovascular iphakanyisiwe.
Ngoko, ubuncinci, ukuba nenqanaba eliphezulu le-CRP kufuneka lenze wena kunye nogqirha wakho kunzulu kakhulu ngokunciphisa umngcipheko. Ukongezelela, idatha evela kwi- JUPITER yophando esandul 'ukugqibela isitshela ukuba ukunika izigulane kwizigulane ezibonakalayo ezinempilo ezinamazinga aphezulu e-CRP zinokunciphisa kakhulu kwaye zinciphisa kakhulu ingozi yesifo senhliziyo.
Umgca ophantsi
Amazinga e-CRP ngokuqinisekileyo akudingeki ukuba alinganiswe kuwo wonke umntu. Ngaphambi kokuba ucinge ngephakamiso ye-CRP, wena kunye nogqirha wakho kufuneka uhlole umngcipheko wakho wesifo sengqondo, esekelwe kwiimeko ezinobungozi . Olu vavanyo luya kukuxelela ukuba unomgangatho ophezulu, ophakathi okanye ophantsi.
Ukuba sele sele usekuhlaleni oluphezulu, ukulinganisa i-CRP akuyi kuba luncedo kakhulu. Unokuthi uhlaselwe sisifo senhliziyo okanye uhlaselwa ngaphandle kokuba unciphise ngokukhawuleza umngcipheko wakho, kungakhathaliseki ukuba yintoni inqanaba lakho le-CRP. Kodwa ukuba wena okanye ugqirha wakho unqikaza ukusebenzisa i- statins , kwaye awuqinisekanga ngenzuzo abanokukunika yona, ngoko ukulinganisa amazinga akho e-CRP kunokukunika esinye isizathu sokuqwalasela le nkunkuma yokunciphisa ingozi.
Kunengqiqo ukulinganisa izinga le-CRP ukuba ungowomgangatho ojongene nengozi. Iphakamileyo yeRPP apha apha kufuneka ithumele iiflegi ezibomvu ezinokuthi umngcipheko wakho uphezulu kunokuba ucinga. Kwakhona, ukuba iinqwelo ze-cholesterol zakho ziqhelekileyo okanye ziphakanyisiwe nje, ngoko ukwazi ukuba i-CRP yakho iphakamileyo iya kunika wena nodokotela wakho isizathu esicacileyo sokuqwalasela unyango ngama-statins.
Ngolwazi lwangoku lwangoku, ukubaluleka kokulinganisa amanqanaba e-CRP kubantu abakwizinga eliphantsi kobungozi kuyacaca kakhulu. Ukuba i-CRP iphakanyisiwe kwaye awunayo enye ingozi, ukusetyenziswa kweemimiselo kunokuqwalaselwa kodwa kunzima kakhulu. Uninzi ogqirha bayavuma ukuba kunesizathu esincinane sokulinganisa amanqanaba e-CRP kubantu abakwizinga elincinci.
Ukuba unayo i-CRP yakho ilinganiswe kwaye iphinda ibuye phezulu, ungathanda ukufunda le nqaku: Yintoni ongayenza xa i-CRP yakho iphakanyisiwe.
Imithombo:
Cook NR, Buring JE, kunye ne-Ridker PM. Impembelelo yokuquka iprotheyini esebenzayo yeC-c kwiimodeli zokubikezela umngcipheko we-cardiovascular risk for women. U-Ann Intern Med 2006; 145: 21-29.
U-Lloyd-Jones DM, u-Liu K, u-Tian L, kunye noGreenland P. Ukuhlaziywa okulandelelanayo: Ukuhlola kweprotheyini esebenzayo ye-C ekuqaphelweni kwengozi yesifo senhliziyo. U-Ann Intern Med 2006; 145: 35-42.
UDavey Smith G, uTimpson N kunye ne-Lawlor D. C-protein esebenzayo kunye nomngcipheko wesifo seengqondo: Ingangakanani into engaziwayo? U-Ann Intern Med 2006; 145: 70-72.
Ridker PM, uDanelson E, uFonseca FA et al. I-Rosuvastatin ukukhusela iziganeko ze-vascular kumadoda nabasetyhini abaneeprotheyini e-C ephezulu. I-Engl J Med 2008; INGXELO: 10.1056 / NEJMoa0807646. Kufumaneka kwi: http://www.nejm.org.